ARDX - Ardelyx, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ARDX (1437402)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
15 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S7-2+1-4+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-11-13
ARDXGrammer Elizabeth AEVP, GCS - Sale$2.84-6,539135,204-5%-$18,571
2018-11-13
ARDXRaab MichaelPres, CEOS - Sale$2.84-6,539362,884-2%-$18,571
2018-11-13
ARDXKaufmann MarkCFOS - Sale$2.84-6,539146,489-4%-$18,571
2018-11-13
ARDXRosenbaum David P.Chief Development OfficerS - Sale$2.84-5,570262,034-2%-$15,819
2018-11-12
ARDXSandell Scott D10%S - Sale$2.98-59215,333,5820%-$1,767
2018-05-30
ARDXRingold GordonDirP - Purchase$4.00+10,00035,000+40%+$40,000
2017-10-24
ARDXSeeto ReginaldCOOS - Sale$5.20-10,008149,885-6%-$52,043
2017-08-30
ARDXBaskett Forest10%S - Sale$4.95-48514,083,5820%-$2,401
2017-04-18
ARDXRosenbaum David P.Chief Development OfficerS - Sale$11.98-2,051118,998-2%-$24,5770+11
2017-03-10
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$13.48-1,000121,049-1%-$13,482+2+6-16
2017-03-03
ARDXCaldwell Jeremy SEVP, Chief Scientific OfficerS - Sale$14.14-1,02617,985-5%-$14,512-3-5-11
D
2017-03-01
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$13.70-3,00068,450-4%-$41,100-3-5-11
D
2017-02-01
ARDXJacobs Jeffrey WSVP, Technical OperationsS - Sale+OE$12.00-3,00067,510-4%-$36,000-1+3+24
2017-01-05
ARDXKorner PaulEVP, Chief Medical OfficerS - Sale$12.95-6,13054,623-10%-$79,3840-30
2016-12-16
ARDXRosenbaum David P.SVP, Drug DevelopmentS - Sale$14.48-900100,372-1%-$13,035-6+1-7
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top